Review of ongoing Aoactivities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future

Simple item page
dc.contributor.authorGodman, Brian
dc.contributor.authorBasu, Debashis
dc.contributor.authorPillay, Yogan
dc.contributor.authorMwita, Julius C.
dc.contributor.authorTiroyakgosi, Celda
dc.contributor.authorRwegerera, Godfrey Mutashambara
dc.contributor.authorOkwen, Patrick Mbah
dc.contributor.authorNiba, Loveline Lum
dc.contributor.authorNonvignon, Justice
dc.contributor.authorSefah, Israel
dc.contributor.authorOluka, Margaret
dc.contributor.authorGuantai, Anastasia N.
dc.contributor.authorKibuule, Dan
dc.contributor.authorKalemeera, Francis
dc.contributor.authorMubita, Mwangana
dc.contributor.authorFadare, Joseph
dc.contributor.authorOgunleye, Olayinka O.
dc.contributor.authorDistiller, Larry A.
dc.contributor.authorRampamba, Enos M.
dc.contributor.authorWing, Jeffrey
dc.contributor.authorMueller, Debjani
dc.contributor.authorAlfadl, Abubakr
dc.contributor.authorAmu, Adefolarin A.
dc.contributor.authorMatsebula, Zinhle
dc.contributor.authorKalungia, Aubrey
dc.contributor.authorZaranyika, Trust
dc.contributor.authorMasuka, Nyasha
dc.contributor.authorWale, Janney
dc.contributor.authorHill, Ruaraidh
dc.contributor.authorKurdi, Amanj
dc.contributor.authorTimoney, Angela
dc.contributor.authorCampbell, Stephen
dc.contributor.authorMeyer, Johanna C.
dc.date.accessioned2023-08-24T08:40:10Z
dc.date.available2023-08-24T08:40:10Z
dc.date.issued2020
dc.descriptionReview article
dc.description.abstractBackground: There has been an appreciable increase in the number of people in Africa with metabolic syndrome and Type 2 diabetes (T2DM) in recent years as a result of a number of factors. Factors include lifestyle changes, urbanisation, and the growing consumption of processed foods coupled with increasing levels of obesity. Currently there are 19 million adults in Africa with diabetes, mainly T2DM (95%), estimated to grow to 47 million people by 2045 unless controlled. This has a considerable impact on morbidity, mortality and costs in the region. There are a number of issues to address to reduce the impact of T2DM including improving detection rates and current access to services alongside addressing issues of adherence to prescribed medicines. There are also high rates of co-morbidities with infectious diseases such as HIV and tuberculosis in patients in Africa with T2DM that require attention. Objective: Document ongoing activities across Africa to improve the care of patients with T2DM especially around issues of identification, access, and adherence to changing lifestyles and prescribed medicines. In addition, discussing potential ways forward to improve the care of patients with T2DM based on ongoing activities and experiences including addressing key issues associated with co-morbidities with infectious diseases. Our Approach: Contextualise the findings from a wide range of publications including internet based publications of national approaches coupled with input from senior level government, academic and other professionals from across Africa to provide future guidance. Ongoing Activities: A number of African countries are actively instigating programmes to improve the care of patients with T2DM starting with improved diagnosis. This recognises the growing burden of non-communicable diseases across Africa, which has been neglected in the past. Planned activities include programmes to improve detection rates and address key issues with diet and lifestyle changes, alongside improving monitoring of care and activities to enhance adherence to prescribed medicines. In addition, addressing potential complexities involving diabetes patients with infectious disease co-morbidities. It is too early to fully assess the impact of such activities, Conclusion: There are a number of ongoing activities across Africa to improve the management of patients with diabetes including co-morbidities. However, more needs to be done considering the high and growing burden of T2DM in Africa. Ongoing research will help further benefit resource allocation and subsequent care. Keywords: Type 2 diabetes, Africa, national initiatives, diagnosis, medicines, adherence, patient groups
dc.description.sponsorshipUniversity of Strathclyde, Nyangabgwe Hospital, Francistown, University of Bamenda, Busitema University
dc.identifier.citationGodman, B., Basu, D., Pillay, Y., Mwita, J. C., Rwegerera, G. M., Anand Paramadhas, B. D., ... & Meyer, J. C. (2020). Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Frontiers in pharmacology, 11, 108.
dc.identifier.urihttps://doi.org/10.60682/0rwa-qy73
dc.language.isoen
dc.publisherFrontiers in pharmacology
dc.relation.ispartofseriesSec. Drugs Outcomes Research and Policies; Volume 11
dc.subjectResearch Subject Categories::MEDICINE::Physiology and pharmacology::Pharmacological research::Pharmacology
dc.titleReview of ongoing Aoactivities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future
dc.typeArticle
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Department of Clinical Phamacology